7820
J. X. de Arau´jo-Ju´nior et al. / Tetrahedron Letters 48 (2007) 7817–7820
R
(CH2)2-R
(CH2)2-R
Br
iii)
ii)
i)
iv)
TsO
O
Ar2
O
N
TsO
O
TsO
O
2c, 3c
N
N
N
N
N
N
N
90-95%
Bn
Bn
Bn
Bn
28, 29
22, 23
24, 25
26, 27
Ar2 = 3,4-(OMe)2-Ph
Yields %
4-substituted compounds: 2c, 22, 24, 26, 28
5-substituted compounds: 3c, 23, 25, 27, 29
R
24 25
91 72
89 95
79 77
26
90
88
99
27
82
88
82
28
91
70
67
29
85
71
85
a
b
c
(CH2)3NHBOC
(CH2)3OBn *
(CH2)3CO2Et
* after hydrogenation OBn→OH
Scheme 7. Introduction of chemical diversity on the pyridazine ring by means of Sonogashira/Suzuki sequential reactions. Reagents and conditions:
(i) CuI, TEA, CH3CN, PdCl2(PPh3)2, (3.5%), Ph-„, lw, 5 min, 80 °C; (ii) TsCL, pyridine; (iii) H2, Pd/C, MeOH; (iv) Ar2B(OH)2, Pd(PPh3)4 (7%),
lw, 30 min, 120 °C.
3. (a) Wermuth, C. G.; Bourguignon, J. J.; Hoffmann, R.;
the tosylate giving the expected pyridazinone 28 (Scheme
7),20 whereas direct Sonogashira-type reaction in the
vicinity of a free NH-amide group gave quantitatively
the furo-pyridazinone 4 (Scheme 2).
´
Boigegrain, R.; Brodin, R.; Kan, J. P.; Soubrie, P. Bioorg.
Med. Chem. Lett. 1992, 2, 833–838; (b) Contreras, J. M.;
Parrot, I.; Sippl, W.; Rival, Y. M.; Wermuth, C. G. J.
Med. Chem. 2001, 44, 2707–2718.
4. Contreras, J. M.; Rival, Y. M.; Chayer, S.; Bourguignon,
J. J.; Wermuth, C. G. J. Med. Chem. 1999, 42, 730–741.
5. Schmitt, M.; Bourguignon, J. J.; Barlin, G. B.; Davies, L.
P. Aust. J. Chem. 1997, 50, 779–785.
6. Albright, J. D.; Moran, D. B.; Wright, W. B.; Collins, J.
B.; Beer, J. B.; Lippa, A. S.; Greenblatt, E. N. J. Med.
Chem. 1981, 78, 592–600.
7. Rival, Y.; Hoffmann, R.; Didier, B.; Rybaltchenko, V.;
Bourguignon, J. J.; Wermuth, C. G. J. Med. Chem. 1999,
41, 311–317.
8. Turck, A.; Ple, N.; Mojovic, L.; Queguiner, G. Diazines
VII. Bull. Soc. Chim. Fr. 1993, 130, 488–492.
9. Ohsawa, A.; Abe, Y.; Igeta, H. Chem. Pharm. Bull. 1980,
28, 3488–3493.
After removal of the protective benzyl group as de-
scribed above, the second amide function opened the
ways to supplementary structural variations around
the pyridazine backbone.
In conclusion the reported methodologies based on the
desymmetrization of pyridazin-3,6-dione by means of
N-benzyl-hydrazine and maleic anhydrides led to valu-
able intermediates possessing up to three different
anchors able to introduce large diversity for the synthe-
sis of regiospecifically poly substituted pyridazines.
10. Goodman, A. J.; Stanforth, S. P.; Tarbit, S. Tetrahedron
1999, 55, 15067–15070.
Acknowledgement
11. Chekmarev, D. S.; Stepanov, A. E.; Kasatkin, A. N.
Tetrahedron Lett. 2005, 46, 1303–1305.
12. Schmitt, M.; de Arau´jo-Ju´nior, J. X.; Bourguignon, J. J.
Mol. Divers. 2006, 10, 429–434.
13. Bourotte, M.; Pellegrini, N.; Schmitt, M.; Bourguignon, J.
J. Synlett 2003, 1482–1484.
Financial supports (Proc No. 0085057) of CAPES/Bra-
zil to J.X.A.-J. and Cofecub are acknowledged. The
authors thank Dr. Gilbert Schlewer for helpful discus-
sions and encouragement.
14. Coelho, A.; Novoa, H.; Peeters, H.; Blaton, N.; Sotelo, E.
Tetrahedron 2003, 61, 4785–4791.
15. Coelho, A.; Sotelo, E.; Ravina, E. Tetrahedron 2003, 59,
2477–2484.
Supplementary data
Supplementary data associated with this article can be
´
16. Crespo, A.; Meyers, C.; Coelho, A.; Yanez, M.; fraiz, N.;
Sotelo, E.; Maes, B. U. W.; Laguna, R.; Cano, E.;
Lemiere, G. L. F.; Ravina, E. Bioorg. Med. Chem. Lett.
`
2006, 16, 1080–1083.
17. de Arau´jo-Ju´nior, J. X.; Schmitt, M.; Benderitter, P.;
Bourguignon, J. J. Tetrahedron Lett. 2006, 47, 6125–6128.
18. Bourguignon, J. J.; Oumouch, S.; Schmitt, M. Curr. Org.
React. 2006, 10, 277–295.
19. Batchelor, M. J.; Mellor, J. M. J. Chem. Soc., Perkin
Trans. 1 1989, 5, 985–995.
20. Supporting information available: Experimental proce-
dures and spectral data. This material is available free of
charge.
21. Microwave irradiation has been performed using biotage
References and notes
1. Wermuth, C. G.; Bourguignon, J. J.; Schlewer, G.; Gies, J.
P.; Schoenfelder, A.; Melikian, A.; Bouchet, M. J.;
Chantreux, D.; Molimard, J. C.; Heaulme, M.; Chambon,
J. P.; Biziere, C. J. Med. Chem. 1987, 30, 239–249.
2. Velentza, A. V.; Wainwright, M. S.; Zasadzki, M.;
Mirzoeva, S.; Schumacher, M.; Haiech, J.; Focia, P. J.;
Egli, M.; Waterson, D. M. Bioorg. Med. Chem. Lett. 2003,
13, 3465–3470.